- 0755-26849287
- bayray@szbl.ac.cn
- Gaoke Innovation Center, Guangming District, Shenzhen City, Guangdong Province (145 meters north of the intersection of Changsheng Road and Guangqiao Road)
Using CRISPR/Cas9 technology, a genome-wide genetic screening platform based on CRISPR will be established to explore potential new drug projects for DDRS, and explore the potential synergistic effect of small molecules targeting DDRS combined with immune checkpoint blocking.
At present, 4 of the centers are working on small molecule anticancer projects (FIC), 1 LO stage and 3 LG stage
International competition compounds: preclinical or Phase 1 clinical.